Abstract
Systemic lupus erythematosus (SLE) and small-sized vessel vasculitis are usually two distinguishable autoimmune diseases. However, a vasculitis may be found in the course SLE but rarely corresponds to an ANCA-associated vasculitis (AAV). We report four cases of de novo SLE associated with AAV, our aim being to discuss the clinical significance of this association. We included four patients fulfilling the criteria for both SLE and AAV and followed in two different university hospitals between 1996 and 2009. In light of a 20-year literature review (25 described clinical cases), we discussed the etiopathogeny of such an association. All patients presented a severe renal involvement (creatininemia ranging from 120 to 370 μmol/l) and thrombopenia (ranging from 45,000 to 137,000 platelets/mm3). The other main clinical symptoms were arthritis (n = 3), serositis (n = 2) and intra-alveolar hemorrhage (n = 2). An inflammatory syndrome was noticed at diagnosis in all cases. ANCAs were MPO-ANCAs in all cases. Two out of these four patients were also diagnosed with antiphospholipid syndrome. The frequency of this association seems not fortuitous. Although the etiopathogenic mechanisms of such an association remain to be more precisely described, several clinical, histological and immunological features support the hypothesis of the existence of a SLE-AAV overlapping syndrome. Moreover, clinicians must be aware of such an overlapping syndrome, notably because its initial presentation can be very severe.
References
La Cava A (2009) Lupus and T cells. Lupus 18(3):196–201
Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3(7–8):516–523
Falk RJ, Jennette JC (2004) Thoughts about the classification of small vessel vasculitis. J Nephrol 17(Suppl 8):S3–S9
Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12(9):651–658
Lee SS, Lawton JW, Chak W (1991) Distinction between antinuclear antibody and P-ANCA. J Clin Pathol 44(11):962–963
Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K (1999) Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18(1):77–81
Cavagna L, Caporali R, Esposito C, Augetti C, Epis O, Montecucco C (2007) Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. Scand J Rheumatol 36(1):74–76
Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T (2008) Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin Exp Nephrol 12(5):393–397
Kobayashi S, Inokuma S (2009) Intrapulmonary haemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions. Intern Med 48(11):891–897
Nasr SH, D’Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3(3):682–690
Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K (1997) Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16(1):70–75
Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35(7):625–631
Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317
Cambridge G, Wallace H, Bernstein RM, Leaker B (1994) Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 33(2):109–114
Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon GE, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J (1998) Anti-neutrophil cytoplasmic anti bodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin Exp Rheumatol 16(5):541–546
Manolova I, Dancheva M, Halacheva K (2001) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 20(5):197–204
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20(1):57–63
Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651–1657
Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF (1992) Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31(10):669–673
Marshall S, Dressler R, D’Agati V (1997) Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 29(1):119–124
Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873
Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81(3):380–383
Akhtar M, al Dalaan A, el Ramahi KM (1994) Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 23(2):320–325
Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141(2):201–210
Masutani K, Tokumoto M, Nakashima H, Tsuruya K, Kashiwagi M, Kudoh Y, Fukuda K, Kanai H, Akahoshi M, Otsuka T, Hirakata H, Iida M (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59(6):395–405
Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4(8):542–548
Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signalling. Arthritis Rheum 48(3):746–756
Conflict of interest
All authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hervier, B., Hamidou, M., Haroche, J. et al. Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?. Rheumatol Int 32, 3285–3290 (2012). https://doi.org/10.1007/s00296-011-2055-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2055-z